Busca
Resultados da Busca
Select an image to start the slideshow
The Association of Alzheimer’s Disease-related Blood-based Biomarkers with Cognitive Test Performance in the Congolese Population
1 of 18
Alzheimer's Disease Associated Genomic Variants Identified in White Populations are Present in African Americans at Risk for Alzheimer's Disease Due to Family History
2 of 18
LCMT-1 is an essential component of neuronal development
3 of 18
Development of Region-Specific Tau Pathology in P301S Mice
4 of 18
Amyloid Precursor Protein Regulation by G Protein-Coupled Receptor 12
5 of 18
From epigenetic memory to memory loss: How tau prevents LSD1 from regulating transcription and induces cell death in Alzheimer’s disease
6 of 18
Neuron-specific cellular functions of Interleukin-9 in Alzheimer’s Disease
7 of 18
Association between Anti-Inflammatory Interleukin-10 and Executive Function in African American Women at risk for Alzheimer's Disease
8 of 18
Characterization of LR11/SorLA in Mild Cognitive Impairment
9 of 18
APOE ε4, but not diabetes, is a risk factor for
Alzheimer's Disease
10 of 18
Identification and characterization of disease-associated proteins
in frontotemporal lobar degeneration
11 of 18
Characterization of the Relationship Between LR11 and Tau Pathology
12 of 18
Aberrant Proteasome Pathway in Alzheimer's Disease at Early
Stage revealed by Whole-Transcriptome Study
13 of 18
M1 Muscarinic Acetylcholine Receptor Signaling and Regulation ofAmyloid Precursor Protein Processing
14 of 18
Genome-wide alteration of 5-hydroxymethylcytosine in a mouse model of Alzheimer's disease
15 of 18
RNA-binding proteins with mixed charge domains self-assemble, aggregate, and interact with core pathologies in Alzheimer's Disease
16 of 18
Amplification of amyloid-beta strains and their connection to tau in Alzheimer’s Disease
17 of 18
Physical Activity May be a Modifiable Risk Factor for Cognitive Decline in African Americans and Caucasians at High Risk for Developing Alzheimer's Disease
18 of 18